| Barriers and facilitators to dispensing of intranasal naloxone by pharmacists |
15 |
| Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states |
12 |
| A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees |
12 |
| Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors |
10 |
| Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration |
10 |
| Understanding the implications of the vaping epidemic among adolescents and young adults: A call for action |
9 |
| Overcoming medication stigma in peer recovery: A new paradigm |
9 |
| A qualitative analysis of interprofessional students? perceptions toward patients with opioid use disorder after a patient panel experience |
8 |
| Marijuana use and mortality following orthopedic surgical procedures |
8 |
| Immediate effects of interoceptive awareness training through Mindful Awareness in Body-oriented Therapy (MABT) for women in substance use disorder treatment |
8 |
| Addressing substance use disorder in primary care: The role, integration, and impact of recovery coaches |
8 |
| Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis |
7 |
| Operating a motor vehicle after marijuana use: Perspectives from people who use high-potency marijuana |
7 |
| Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention |
7 |
| Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis? |
7 |
| Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance |
7 |
| Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs? |
6 |
| Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors |
6 |
| Utilization of buprenorphine and methadone among opioid users who inject drugs |
6 |
| Interest in using mobile technology to help self-manage alcohol use among persons living with the human immunodeficiency virus: A Florida Cohort cross-sectional study |
6 |
| Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply |
6 |
| Socioeconomic and geographical disparities in prescription and illicit opioid-related overdose deaths in Orange County, California, from 2010-2014 |
6 |
| An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines |
6 |
| Trajectories of cannabis use beginning in adolescence associated with symptoms of posttraumatic stress disorder in the mid-thirties |
5 |
| Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters |
5 |
| The willingness of people who inject drugs in Boston to use a supervised injection facility |
5 |
| Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness |
5 |
| Hepatitis C cascade of care among people who inject drugs in Vancouver, Canada |
5 |
| Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature |
5 |
| Randomized pilot trial measuring knowledge acquisition of opioid education in emergency department patients using a novel media platform |
5 |
| Lessons learned from the implementation of a medically enhanced residential treatment (MERT) model integrating intravenous antibiotics and residential addiction treatment |
5 |
| Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes |
5 |
| Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report |
4 |
| Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program |
4 |
| Adults who misuse opioids: Substance abuse treatment use and perceived treatment need |
4 |
| Use of non-face-to-face modalities for emergency department screening, brief intervention, and referral to treatment (ED-SBIRT) for high-risk alcohol use: A scoping review |
4 |
| Effectiveness of pharmacological or psychological interventions for smoking cessation in smokers with major depression or depressive symptoms: A systematic review of the literature |
4 |
| The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland |
4 |
| An opioid overdose curriculum for medical residents: Impact on naloxone prescribing, knowledge, and attitudes |
4 |
| Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study |
3 |
| Motivational interviewing training of substance use treatment professionals: A systematic review |
3 |
| Pharmacy: Addressing substance use in the 21st century |
3 |
| Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness |
3 |
| Past-year nonmedical use of prescription drugs among women on probation and parole: A cross-sectional study |
3 |
| Childhood trauma, combat trauma, and substance use in National Guard and reserve soldiers |
3 |
| Evaluation of the Substance Abuse Research and Education Training (SARET) program: Stimulating health professional students to pursue careers in substance use research |
3 |
| Screening, brief intervention, and referral to treatment (SBIRT) curriculum integration and sustainability: Social work and nursing faculty perspectives |
3 |
| Experiences of burnout among drug counselors in a large opioid treatment program: A qualitative investigation |
3 |
| Knowledge of the 911 Good Samaritan Law and 911-calling behavior of overdose witnesses |
3 |
| Opioid discontinuation as an institutional mandate: Questions and answers on why we wrote to the Centers for Disease Control and Prevention |
3 |
